This
paper describes a novel approach to CO2 hydrogenation,
in which CO2 capture with aminoethanols at low pressure
is coupled with hydrogenation of the captured product, oxazolidinone,
directly to MeOH. In particular, (2-methylamino)ethanol or valinol
captures CO2 at 1–3 bar in the presence of catalytic
Cs2CO3 to give the corresponding oxazolidinones
in up to 65–70 and 90–95% yields, respectively. Efficient
hydrogenation of oxazolidinones was achieved using PNN pincer Ru catalysts
to give the corresponding aminoethanol (up to 95–100% yield)
and MeOH (up to 78–92% yield). We also have shown that both
CO2 capture and oxazolidinone hydrogenation can be performed
in the same reaction mixture using a simple protocol that avoids intermediate
isolation or purification steps. For example, CO2 can be
captured by valinol at 1 bar with Cs2CO3 catalyst
followed by 4-isopropyl-2-oxazolidinone hydrogenation in the presence
of a bipy-based pincer Ru catalyst to produce MeOH in 50% yield after
two steps.
Metal-ligand cooperation (MLC) plays an important role in catalysis. Systems reported so far are generally based on a single mode of MLC. We report here a system with potential for MLC by both amine-amide and aromatization-dearomatization ligand transformations, based on a new class of phosphino-pyridyl ruthenium pincer complexes, bearing sec-amine coordination. These pincer complexes are effective catalysts under unprecedented mild conditions for acceptorless dehydrogenative coupling of alcohols to esters at 35 °C and hydrogenation of esters at room temperature and 5 atm H2. The likely actual catalyst, a novel, crystallographically characterized monoanionic de-aromatized enamido-Ru(II) complex, was obtained by deprotonation of both the N-H and the methylene proton of the N-arm of the pincer ligand.
Herein, the first example of base-metal-catalyzed dehydrogenative coupling of diols and amines to selectively form functionalized 1,2,5-substituted pyrroles liberating water and hydrogen gas as the sole by-products is presented. The reaction is catalyzed by pincer complexes of earth-abundant cobalt.
Design of highly efficient phosphorescent emitters based on metal- and heavy atom-free boron compounds has been demonstrated by taking advantage of the singlet fission process. The combination of a suitable molecular scaffold and appropriate electronic nature of the substituents has been utilized to tailor the phosphorescence emission properties in solution, neat solid, and in doped PMMA thin films.
A series of novel luminescent cyclometalated Au(III) neutral complexes of the type cis-[(N(∧)C)AuL] [N(∧)C = 2-phenylpyridine (ppy), L = 1,1'-biphenyl (1)] and cis-[(N(∧)C)AuL(2)] [N(∧)C = 2-phenylpyridine (ppy), L = C(6)H(5) (2), C(6)F(5) (3), C(6)H(4)-CF(3)-p (4), 2-C(4)H(3)S (5)]; [N(∧)C = 2-(2-thienyl)pyridine (thpy), L = C(6)H(5) (6), C(6)F(5) (7)]; [N(∧)C = 2-(5-methyl-2-thienyl)pyridine (5 m-thpy), L = C(6)F(5) (8)] were successfully synthesized. The X-ray crystal structures of all compounds except 3 have been determined. These complexes were found to show long-lived emission in solution at room temperature. The emission origins of the complexes have been tentatively assigned to be derived from triplet states predominantly bearing intraligand (IL) character with some perturbation from the metal center. Density functional theory (DFT) calculations were performed to evaluate the stability associated with the complexes and TD-DFT calculations to ascertain the nature of the excited state. Variation of the cyclometalated ligands in the complexes readily leads to the tuning of the nature of the lower energy emissive states.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.